www.fdanews.com/articles/180556-fda-grants-marketing-clearance-to-cepheids-xpert-xpress-flu-and-xpert-xpress-flursv
FDA Grants Marketing Clearance to Cepheid’s Xpert Xpress Flu And Xpert Xpress Flu/RSV
February 15, 2017
Cepheid has received marketing clearance from the FDA for their Xpert Xpress Flu and Xpert Xpress Flu/RSV.
The built-in redundancy results reduce the impact of seasonal genomic drift in flu viruses that has been a problem with molecular tests.
Both tests deliver results in 20 minutes. — Cynthia Jessup